A

ACRS

Aclaris Therapeutics Inc

4.200

+0.060+1.45%
After Hours: 4.190  -0.010  -0.24%17:48 04/02 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE4.050/4.140
TODAY RANGE4.012-4.220
VOL940.07K
MARKET CAP506.50M
52 WEEK RANGE1.050-4.890
AVG VOL (3M)2.38M
% TURNOVER0.78%
TURNOVER--
P/E (TTM)-7.9290
% RANGE5.02%
EPS(TTM)-0.5297
P/E(FORWARD)-6.5625
P/B4.909
BVPS0.8555
DIVIDEND--
P/S64.71
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP493.23M
SHARES OUTSTANDING120.60M
NEXT EARNINGS05/06-05/11
FREE FLOAT117.44M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

ACRS

--

R

Regeneron Pharmaceuticals

REGN

-1.98%
761.85

GRDX

--

B

BIONTECH

BNTX

+1.97%
91.18

聯合治療

UTHR

-0.96%
564.81

VRTX

--

S

SIGA科技

SIGA

+1.35%
5.24

M

Moderna

MRNA

-1.66%
49.20

CRL

--

MEDP

--

TLPH

--

ICLR

--

CBPO

--

IQV

--

M

MOLECULAR PARTNERS AG

MOLN

-3.87%
3.850

A

Arcturus醫療

ARCT

+2.29%
8.03

GILD

--

PRAH

--

I

Incyte Corp

INCY

+1.73%
95.93

APVO

--

B

BioSpecifics生物

BSTC

+0.15%
88.53

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.